Osteoarthrosis
3
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
M&
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program1
Chondroitin 4&6 sulfatePhase 31 trial
Active Trials
UP
UCB PharmaBelgium - Brussels
1 program1
10 mg of Hydrocodone Bitartrate Extended ReleasePhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Merck & Co.ReCap, Hip resurfacing system, Biomet
IBSA Institut BiochimiqueChondroitin 4&6 sulfate
UCB Pharma10 mg of Hydrocodone Bitartrate Extended Release
Clinical Trials (3)
Total enrollment: 37 patients across 3 trials
A Comparison of Two Total Hip Replacements: Hip Resurfacing System Versus Mallory-Head/Exeter
Start: Jan 2005Est. completion: Jan 2012
Phase 4Completed
Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand
Start: Jun 2005Est. completion: Aug 2010
Phase 3Completed
A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis Pain
Start: Sep 2002Est. completion: Dec 200237 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space